Recent Cancer Drugs Approved by the FDA.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 2, p. 25
- Publication type:
- Article
Works matching IS 21641153 AND DT 2014 AND VI 4 AND IP 2
Results: 8
1
2
HOPA's 10-Year Anniversary Marks Rapid Developments in Hematology/ Oncology Pharmacy.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 2, p. 23
- Publication type:
- Article
3
Comparing Chemotherapy and EGFR Kinase Inhibitors for Patients with Advanced NSCLC and Wild-Type EGFR.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 2, p. 21
- Publication type:
- Article
4
Dovitinib Active, but Not Superior to Sorafenib, in Patients with Metastatic Renal Cancer.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 2, p. 20
- Publication type:
- Article
5
Rituximab Active in Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 2, p. 19
- Publication type:
- Article
6
ALK- Positive Non-Small-Cell Lung Cancer Responds to Ceritinib Treatment.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 2, p. 18
- Publication type:
- Article
7
Concise Review of Obinutuzumab in the Treatment of Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 2, p. 10
- By:
- Publication type:
- Article
8
A Retrospective Chart Review on the Toxicity of Pegylated Asparaginase in Adult Patients with Acute Lymphoblastic Leukemia.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2014, v. 4, n. 2, p. 1
- By:
- Publication type:
- Article